Figure 1From: Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomySurvival and loco-regional recurrence after treatment for loco-regionally recurrent breast cancer. No significant difference was seen between standard and dose-escalated groups in LRR (A), DFS (B), OS (C) or DMFS (D) after XRT.Back to article page